What are the emerging trends and challenges with targeted therapies for blood cancer today? How does single-cell analysis impact the study of therapy response and resistance mechanisms? We invited two experts in the field of hematology, Dr. Michael Andreeff of MD Anderson Cancer Center and Dr. Peter Valk of Erasmus MC for a round table discussion on various single-cell technologies available today and they are used to tackle therapy resistance.
